Hamilton Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$372K Sell
404
-718
-64% -$728K 0.07% 81
2025
Q4
$1.21M Buy
1,122
+409
+57% +$391K 0.23% 50
2025
Q3
$544K Buy
713
+369
+107% +$275K 0.11% 64
2025
Q2
$268K Sell
344
-5,310
-94% -$4.13M 0.06% 86
2025
Q1
$4.67M Buy
5,654
+13
+0.2% +$10.8K 1.12% 21
2024
Q4
$4.35M Buy
5,641
+630
+13% +$522K 1.06% 26
2024
Q3
$4.44M Buy
5,011
+4,445
+785% +$4M 1.09% 24
2024
Q2
$512K Sell
566
-3
-0.5% -$2.4K 0.14% 50
2024
Q1
$443K Sell
569
-5
-0.9% -$3.56K 0.14% 62
2023
Q4
$335K Hold
574
0.11% 67
2023
Q3
$308K Hold
574
0.11% 70
2023
Q2
$269K Buy
+574
New +$241K 0.09% 78

Other funds holding LLY

Hamilton Wealth's LLY Position: Q1 2026 in Review

Hamilton Wealth reduced its Eli Lilly (LLY) stake by 64% in Q1 2026, selling an estimated $728K and leaving 404 shares worth $372K. The position accounts for 0.07% of the portfolio, ranked #81.

Hamilton Wealth first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $4.67M in Q1 2025. 4,356 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Hamilton Wealth held 404 shares of Eli Lilly worth $372K as of Q1 2026.
  • Hamilton Wealth sold 718 Eli Lilly shares in Q1 2026, an estimated $728K.
  • Eli Lilly made up 0.07% of Hamilton Wealth's portfolio in Q1 2026, its #81 holding.
  • Hamilton Wealth first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • Hamilton Wealth's Eli Lilly position peaked at $4.67M in Q1 2025.
  • 4,356 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hamilton Wealth's 13F filing for Q1 2026, filed 18 May 2026.